Cargando…

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm

PURPOSE: In the present study, we investigated the treatment efficacy and clinical outcomes of botulinum neurotoxin-A (BoNT-A) administered for longer than 5 years to patients with essential blepharospasm. METHODS: We retrospectively reviewed 19 patients (male : female = 8 : 11) diagnosed with essen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seunghyun, Park, Sangrye, Lew, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801084/ https://www.ncbi.nlm.nih.gov/pubmed/29376224 http://dx.doi.org/10.3341/kjo.2017.0030

Ejemplares similares

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jang, Jeongkyeong, et al.
Publicado: (2021)

Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm
por: Sung, Youngje, et al.
Publicado: (2015)

Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects
por: Anwar, M Shakaib, et al.
Publicado: (2013)

Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy
por: Alexandru, Hanganu, et al.
Publicado: (2016)

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
por: Wabbels, Bettina, et al.
Publicado: (2011)

Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm
por: Yang, Hui, et al.
Publicado: (2016)

Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
por: Wenninger, Fiona Carolin, et al.
Publicado: (2022)

THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM
por: Gaćina, Klara, et al.
Publicado: (2022)

Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy
por: Hanganu, Alexandru, et al.
Publicado: (2017)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
por: Park, Y. C., et al.
Publicado: (1993)

Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm
por: Ho, Ren-Wen, et al.
Publicado: (2018)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
por: Hassell, Travis J.W., et al.
Publicado: (2020)

Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014)

Botulinum toxin injections for blepharospasm prior to ocular surgeries
por: Okumus, Seydi, et al.
Publicado: (2012)

Botulinum Neurotoxin Type a Injection Combined with Absorbable Punctal Plug Insertion: An Effective Therapy for Blepharospasm Patients with Dry Eye
por: Ndikumukiza, Malachie, et al.
Publicado: (2023)

Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia
por: O'Flynn, Lena C., et al.
Publicado: (2022)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
por: Leplow, Bernd, et al.
Publicado: (2017)

Management of Essential Blepharospasm
por: Clayman, Eric, et al.
Publicado: (2017)

Blepharospasm Patients after Botulinum Toxin – Sleep Approach
por: Lestingi, Silvia, et al.
Publicado: (2023)

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin, Bo, et al.
Publicado: (2021)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

The Changes in Corneal Astigmatism after Botulinum Toxin-A Injection in Patients with Blepharospasm
por: Moon, Nam Ju, et al.
Publicado: (2006)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong, Hongjuan, et al.
Publicado: (2018)

Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapy
por: Balal, Mehmet, et al.
Publicado: (2023)

Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm
por: Yahalom, Gilad, et al.
Publicado: (2022)

Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
por: Maneksha, V, et al.
Publicado: (2021)

Possible role of frankincense in the treatment of benign essential blepharospasm
por: Baker, Mikayla J., et al.
Publicado: (2023)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up
por: Dreissen, Yasmine EM, et al.
Publicado: (2020)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
por: Schaefer, Sara M., et al.
Publicado: (2015)

Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm – A Randomized Pilot Study
por: Silkiss, Rona Z., et al.
Publicado: (2023)

Clinical Features of Benign Essential Blepharospasm in Korean Patients
por: Lee, Jeong Min, et al.
Publicado: (2018)

Comparison of botulinum neurotoxin type A formulations in Asia
por: Frevert, Jürgen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8qcguom92bk9hshtv6p1mnikfr